Headlands Technologies LLC Editas Medicine, Inc. Transaction History

Headlands Technologies LLC

  • $834 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$7.03 - $11.07 $55,262 - $87,021
7,861 Added 481.68%
9,493 $70,000
Q4 2023

Feb 02, 2024
BUY
$6.25 - $11.11 $10,200 - $18,131
1,632 New
1,632 $16,000
Q2 2023

Aug 03, 2023
BUY
$6.36 - $11.47 $36,620 - $66,044
5,758 New
5,758 $47,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email